Suchergebnisse - androgen deprivation therapy (ADT)

1

Therapiesituation beim metastasierten kastrationsnaiven Prostatakarzinom (mCNPC) und die Auswirkungen im klinischen Alltag

von: Wülfing, C.

2019, in: Der Urologe

Wird geladen...
2

Intermittent versus continuous cyproterone acetate in bone metastatic prostate cancer: results of a randomized trial

von: Verhagen, Paul C. M. S.

2013, in: World journal of urology

Wird geladen...
3

Prospective study on the effect of short-term androgen deprivation therapy on PSMA uptake evaluated with 68Ga-PSMA-11 PET/MRI in men with treatment-naïve prostate cancer

von: Ettala, Otto

2019, in: European journal of nuclear medicine and molecular imaging

Wird geladen...
4

Hormonal Therapies for Patients with Advanced Prostate Cancer

von: Cora N. Sternberg

2016, in: European Medical Journal

Wird geladen...
5

Antiandrogene Therapie des Prostatakarzinoms

von: Rohayem, J.

2012, in: Der Urologe

Wird geladen...
6

Kardiovaskuläre Risikopatienten unter Androgenentzugstherapie

von: Merseburger, Axel S.

2015, in: Der Urologe

Wird geladen...
7

Testosteron im Management des metastasierten Prostatakarzinoms

von: Wolff, J.M.

2015, in: Der Urologe

Wird geladen...
8

Quality of life effects of androgen deprivation therapy in a prostate cancer cohort in New Zealand: can we minimize effects using a stratification based on the aldo-keto reductase family 1, member C3 rs12529 gene polymorphism?

von: Karunasinghe, Nishi

2016, in: BMC urology

Wird geladen...
9

Flare on [18F]PSMA-1007 PET/CT after short-term androgen deprivation therapy and its correlation to FDG uptake: possible marker of tumor aggressiveness in treatment-naïve metastatic prostate cancer patients

von: Malaspina, Simona

2022, in: European journal of nuclear medicine and molecular imaging

Wird geladen...
10

Role of Androgen Receptor-Targeted Agents in Localized Prostate Cancer

von: Jure Murgić

2022, in: Acta Clinica Croatica

Wird geladen...
11

Clinical pharmacology and regulatory consequences of GnRH analogues in prostate cancer

von: Eckstein, Niels

2014, in: European journal of clinical pharmacology

Wird geladen...
12

The Role of Androgen Receptor in Cross Talk Between Stromal Cells and Prostate Cancer Epithelial Cells

von: Qianyao Tang

2021, in: Frontiers in Cell and Developmental Biology

Wird geladen...
13

Role of 64$ CuCl_{2} $ PET/CT in staging of prostate cancer

von: Capasso, Enza

2015, in: Annals of nuclear medicine

Wird geladen...
14

Is the detection rate of 18F-choline PET/CT influenced by androgen-deprivation therapy?

von: Chondrogiannis, Sotirios

2014, in: European journal of nuclear medicine and molecular imaging

Wird geladen...
15

Androgen Receptor Signaling in Salivary Gland Cancer

von: Martin G. Dalin

2017, in: Cancers

Wird geladen...
16

Association between SARS-CoV-2 infection and disease severity among prostate cancer patients on androgen deprivation therapy: a systematic review and meta-analysis

von: Sari Motlagh, Reza

2021, in: World journal of urology

Wird geladen...
17

Evaluation of pharmacokinetics/pharmacodynamics and efficacy of one-month depots of TAK-448 and TAK-683, investigational kisspeptin analogs, in male rats and an androgen-dependent prostate cancer model

von: Tanaka, Akira

2018transfer abstract, in: Mexican student-teachers’ “English” language praxicum: Decolonizing attempts

Wird geladen...
18

Impact of androgen deprivation therapy on mood, cognition, and risk for AD

von: Cherrier, Monique M.

2019, in: Urologic oncology

Wird geladen...
19

Androgen deprivation therapy improves the in vitro capacity of high-density lipoprotein (HDL) to receive cholesterol and other lipids in patients with prostate carcinoma

von: Albuquerque, Cicero P.

2020, in: Lipids in health and disease

Wird geladen...
20

Integrating diet and exercise into care of prostate cancer patients on androgen deprivation therapy

von: Moyad MA

2016, in: Research and Reports in Urology

Wird geladen...

Nicht das Richtige dabei?

Schreiben Sie uns!